BiotechTube
Home/InterShunt/Lisa Ingham
LI

Lisa Ingham

VP Clinical & Regulatory Affairs

InterShunt

Therapeutic Areas

CardiovascularHeart Failure

InterShunt Pipeline

DrugIndicationPhase
Percutaneous Atrial Shunt Catheter System (PAS-C)Symptomatic Heart Failure (with elevated left atrial pressure)Pre-clinical

Leadership Team at InterShunt

HS
Harlee Sorkin
CEO
MW
Maggie Wallner
VP Clinical Development
EC
Eugene Chung, MD
CMO
ZT
Zack Tegels
VP of R&D
View full InterShunt profile